2025
JUNE
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 6
314
IRON DEFICIENCY ANEMIA LABORATORY
Tursunaliyeva Hojirakhon
Teacher of the Department of Hospital Therapy, Fergana Public Health Medical Institute
Ahmadaliyeva Sitora
Fergana Public Health Medical Institute, group 3222 student
https://doi.org/10.5281/zenodo.15637278
Abstract.
Iron deficiency anemia is one of the most widespread hematological disorders
in the world, primarily resulting from insufficient iron levels in the div. This condition impairs
hemoglobin synthesis, leading to reduced oxygen transport and various clinical symptoms such
as fatigue, pallor, and weakness. Laboratory investigations play a central role in diagnosing this
type of anemia, differentiating it from other forms, and guiding appropriate treatment. Key
laboratory tests include a complete blood count, serum iron analysis, ferritin level measurement,
and evaluation of red blood cell morphology. These tests help detect changes such as low
hemoglobin concentration, microcytic and hypochromic red blood cells, and depleted iron
stores. Interpretation of these results within the clinical context ensures accurate diagnosis and
effective monitoring of therapy.
Keywords:
Anemia, Iron deficiency, Hemoglobin, Red blood cells, Ferritin, Serum iron,
Transferrin.
ЛАБОРАТОРИЯ ЖЕЛЕЗОДЕФИЦИТНОЙ АНЕМИИ
Аннотация.
Железодефицитная анемия является одним из наиболее
распространенных гематологических заболеваний в мире, в первую очередь возникающим
из-за недостаточного уровня железа в организме. Это состояние нарушает синтез
гемоглобина, что приводит к снижению транспорта кислорода и различным клиническим
симптомам, таким как усталость, бледность и слабость. Лабораторные исследования
играют центральную роль в диагностике этого типа анемии, дифференциации ее от
других форм и определении соответствующего лечения. Основные лабораторные
анализы включают общий анализ крови, анализ сывороточного железа, измерение уровня
ферритина и оценку морфологии эритроцитов. Эти тесты помогают обнаружить
такие изменения, как низкая концентрация гемоглобина, микроцитарные и гипохромные
эритроциты и истощенные запасы железа. Интерпретация этих результатов в
клиническом контексте обеспечивает точную диагностику и эффективный мониторинг
терапии.
Ключевые слова:
Анемия, Дефицит железа, Гемоглобин, Эритроциты, Ферритин,
Сывороточное железо, Трансферрин.
Introduction
Iron deficiency anemia is the most widespread type of anemia in the world and remains a
significant global health challenge. It primarily results from an insufficient amount of iron in the
div, which leads to a decrease in the production of hemoglobin, the protein responsible for
carrying oxygen in the blood. As a result, the oxygen delivery to the div’s tissues is impaired,
leading to symptoms such as fatigue, weakness, dizziness, rapid heartbeat, pale skin, and brittle
hair and nails. This form of anemia is especially common among women of reproductive age,
2025
JUNE
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 6
315
pregnant women, and children, due to increased iron requirements. Despite its high prevalence,
the condition often goes undiagnosed in its early stages because its symptoms are nonspecific
and can easily be attributed to other health issues or general tiredness.
Main part
Iron deficiency anemia is a hematological disorder characterized by a lack of adequate
iron in the div, which leads to a decreased production of hemoglobin. This condition limits the
blood's ability to carry oxygen efficiently, resulting in systemic symptoms. It is the most
common nutritional deficiency anemia worldwide and affects people of all ages and
backgrounds. Women of reproductive age and children are particularly vulnerable. According to
global health statistics, nearly two billion individuals are affected by this condition. Iron
deficiency anemia is not only a medical concern but also a socio-economic issue, as it reduces
work capacity and impairs cognitive development. It is a preventable and treatable condition, yet
underdiagnosed in many cases. Therefore, public health initiatives aim to improve early
detection and management. Understanding its global significance is the first step toward
effective control. Proper diagnosis relies heavily on laboratory investigations and biochemical
analysis.
The causes of iron deficiency anemia are diverse and can be grouped into three main
categories: insufficient dietary intake, impaired absorption, and chronic blood loss. Inadequate
dietary iron intake is common in populations relying on plant-based diets with low iron
bioavailability. Gastrointestinal disorders such as celiac disease or chronic gastritis can lead to
poor absorption of iron. Chronic blood loss due to conditions like peptic ulcers, heavy
menstruation, or parasitic infections is a major contributor. Pregnant women often develop
anemia due to increased iron demands for fetal development. Infants and adolescents may also
face a higher risk due to rapid growth phases. Repeated blood donation or certain medications
can also deplete iron stores. Recognizing these risk factors is vital for both prevention and
appropriate laboratory testing. The underlying cause must always be identified before initiating
treatment. Each patient’s history provides critical information that complements laboratory data.
Iron deficiency anemia often presents with nonspecific clinical symptoms, making it
challenging to diagnose without laboratory testing. Common symptoms include fatigue,
weakness, dizziness, and shortness of breath. In more severe cases, individuals may experience
chest pain, palpitations, and cognitive disturbances. Specific signs such as pale skin, spoon-
shaped nails, and dry mouth may also be observed. The pathophysiological basis of the disease
involves impaired hemoglobin synthesis due to insufficient iron, which leads to the production of
smaller and paler red blood cells. Oxygen delivery to tissues becomes compromised, resulting in
tissue hypoxia. Over time, compensatory mechanisms such as increased cardiac output and
respiratory rate try to maintain oxygen balance. In children, this can result in developmental
delays and behavioral issues. Understanding the pathophysiology aids clinicians in interpreting
lab results in context. The duration and severity of iron depletion correlate with the intensity of
clinical symptoms.
Laboratory evaluation is essential in confirming the diagnosis of iron deficiency anemia
and differentiating it from other types of anemia. A complete blood count is usually the first step,
revealing low hemoglobin, low hematocrit, and microcytic, hypochromic red blood cells. Red
2025
JUNE
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 6
316
cell indices such as mean corpuscular volume and mean corpuscular hemoglobin are typically
reduced. Serum iron studies are also critical and include measuring serum iron levels, total iron-
binding capacity, and transferrin saturation. Ferritin measurement is considered the most
sensitive indicator of iron stores and typically appears low in iron deficiency. Inflammatory
conditions can mask ferritin levels, which may require additional testing. Reticulocyte
hemoglobin content and soluble transferrin receptor levels are newer markers used in advanced
settings. Peripheral blood smear analysis can provide morphological evidence of iron-deficient
erythropoiesis. These methods together offer a comprehensive diagnostic approach.
Accurate interpretation of laboratory data is crucial to confirm iron deficiency anemia
and exclude other causes such as anemia of chronic disease or thalassemia. Low hemoglobin and
hematocrit values suggest anemia, but they are not specific. A low mean corpuscular volume and
mean corpuscular hemoglobin suggest microcytic hypochromic anemia, which is typical for iron
deficiency. Serum iron is often low, while total iron-binding capacity is elevated due to increased
production of transferrin. Ferritin levels are typically decreased, confirming depleted iron stores.
However, ferritin is an acute phase reactant and may be falsely elevated in inflammatory
conditions. Transferrin saturation below 15 percent is highly suggestive of iron deficiency. A
careful assessment of all parameters in the clinical context is necessary for accurate diagnosis.
Advanced tests like soluble transferrin receptor can help in ambiguous cases. Combining
laboratory data with clinical information leads to the best outcomes.
Recent technological advancements have improved the sensitivity, specificity, and speed
of laboratory tests for iron deficiency anemia. Automated hematology analyzers now provide
detailed red cell indices and reticulocyte parameters, which allow earlier detection of anemia.
Modern immunoassay techniques enable precise measurement of serum ferritin and soluble
transferrin receptor levels. Flow cytometry and advanced imaging can offer insights into iron
status at the cellular level. Point-of-care testing devices are also being developed for rapid
screening in community settings. Molecular diagnostics may assist in distinguishing inherited
forms of anemia. Standardization of laboratory methods has also improved result comparability
between laboratories. These innovations not only help in early diagnosis but also in monitoring
treatment response effectively. The integration of artificial intelligence in laboratory data
analysis is an emerging field with promising potential. Overall, modern diagnostics contribute
significantly to personalized anemia management.
Understanding laboratory findings is essential for guiding the treatment of iron deficiency
anemia. Iron supplements, usually administered orally, are the first line of therapy. In cases of
malabsorption or intolerance, intravenous iron may be considered. Laboratory monitoring during
treatment includes regular checks of hemoglobin, hematocrit, and reticulocyte count. A rise in
reticulocytes within one week often indicates a good response to therapy. Hemoglobin levels are
expected to increase over a few weeks, and full correction may take several months. Ferritin
levels are monitored to assess replenishment of iron stores and prevent relapse. Laboratory
testing also helps identify non-responders and adjust the treatment plan accordingly. In certain
cases, repeat testing may uncover an underlying issue such as chronic bleeding or coexisting
disease. Thus, laboratory follow-up is a vital component of successful anemia management.
Regular monitoring helps ensure complete and sustained recovery.
2025
JUNE
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 6
317
REFERENCES
1.
Turgeon, M. L. (2017).
Clinical Hematology: Theory and Procedures
(6th ed.). Elsevier
Health Sciences.
2.
Greer, J. P., Arber, D. A., Glader, B., List, A. F., Means, R. T., Paraskevas, F., &
Rodgers, G. M. (2018).
Wintrobe's Clinical Hematology
(14th ed.). Wolters Kluwer.
3.
Means, R. T. Jr. (2020). Iron deficiency anemia: A common and curable disease.
American Society of Hematology Education Program
, 2020(1), 282-288.
4.
Tursunaliyeva, H. (2025). METHODS OF DETECTION AND DIAGNOSTIC OF
DISEASES IN CLINICAL BLOOD ANALYSIS.
Modern Science and Research
,
4
(5),
50-54.
5.
Tursunaliyeva, H. (2025). DIAGNOSTIC SIGNIFICANCE OF URINALYSIS IN
DETECTION OF DISEASES.
Modern Science and Research
,
4
(5), 54-56.
6.
Абдуллажанов, Х. М., & Абдужабборов, Ш. А. (2023). ПРОБЛЕМА
ПОСЛЕОПЕРАЦИОННОЙ ТОШНОТЫ И РВОТЫ В АМБУЛАТОРНОЙ
ХИРУРГИИ У ДЕТЕЙ РАННЕГО ВОЗРАСТА.
Экономика и социум
, (5-1 (108)),
357-362.
7.
Abdujabborov, S. (2025). ENSURING THE EFFECTIVENESS AND SAFETY OF
ANESTHESIA PROTECTION METHODS IN
CHILDREN'S OUTPATIENT
SURGERY.
Modern Science and Research
,
4
(4), 1707-1711.
8.
Абдукадирова, Д. Т., Абдукадиров, У. Т., & Жабборов, А. А. (2022).
ДИАБЕТИЧЕСКАЯ
ПОЛИНЕЙРОПАТИЯ:
ПУТИ
ПОЛНОЦЕННОЙ
КОРРЕКЦИИ НЕВРОЛОГИЧЕСКОГО ДЕФИЦИТА.
Новости образования:
Исследование в XXI веке
, 306.
9.
Джабборов, А. А. О. (2025, February). ОСОБЕННОСТИ ПОРАЖЕНИЯ
ПЕРИФЕРИЧЕСКОЙ НЕРВНОЙ СИСТЕМЫ У БОЛЬНЫХ САХАРНЫМ
ДИАБЕТОМ II ТИПА И АЛГОРИТМ ПРОФИЛАКТИКИ. In
Scientific Conference
on Multidisciplinary Studies
(pp. 158-164).
10.
Akmaljon o’g’li, J. A. (2025). Characteristics of Peripheral Nervous System Damage in
Patients with Type 2 Diabetes Mellitus.
Miasto Przyszłości
,
57
, 94-100.
